Karin Jordan

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein et al. · Annals of Oncology · 2012 · 1.5K citations · Full text

Esmo Consensus Guidelines, Personalized Approach, Gastrointestinal Oncology +9

Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management

Alexander Stein, Wieland Voigt, Karin Jordan · Therapeutic Advances in Medical Oncology · 2009 · 409 citations · Full text

Gastrointestinal Pharmacology, Gastroenterology, Pathology +16

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study

Bernardo L. Rapoport, Karin Jordan, Judith A. Boice et al. · Supportive Care in Cancer · 2009 · 233 citations

Emetogenic Chemotherapies, Oncology, Chemotherapy-induced Nausea +9

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment

Hans‐Joachim Schmoll, Matti Aapro, S. Poli-Bigelli et al. · Annals of Oncology · 2006 · 233 citations

Oncology, Medicine, Metronomic Therapy +6

A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy

Richard J. Gralla, Snežana Bošnjak, A. Hontsa et al. · Annals of Oncology · 2014 · 188 citations · Full text